Skip to Main content Skip to Navigation
Journal articles

Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy

Clarice Groeneveld Jacqueline Fontugne Luc Cabel Isabelle Bernard-Pierrot 1 François Radvanyi 1 yves Allory Aurélien de Reyniès 
1 Centre de recherche de l'Institut Curie [Paris]
Document type :
Journal articles
Complete list of metadata
https://hal-cnrs.archives-ouvertes.fr/hal-03453779
Contributor : Isabelle Bernard-Pierrot Connect in order to contact the contributor
Submitted on : Sunday, November 28, 2021 - 7:23:19 PM
Last modification on : Monday, November 29, 2021 - 3:06:18 AM

Identifiers

Collections

CNRS | FNCLCC | CURIE

Citation

Clarice Groeneveld, Jacqueline Fontugne, Luc Cabel, Isabelle Bernard-Pierrot, François Radvanyi, et al.. Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy. European Journal of Cancer, Elsevier, 2021, 148, pp.181-189. ⟨10.1016/j.ejca.2021.01.036⟩. ⟨hal-03453779⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

8